Know Labs, INC 8-K filings

USBC, Inc. has drawn an additional $3.0 million under its Master Loan Agreement and continues to progress with its tokenized deposit product development and pilot programs.

USBC, Inc. has drawn an additional $5.0 million under its Master Loan Agreement, bringing the total outstanding to $15.0 million, while continuing development and testing of its tokenized deposit product with Vast Bank.

USBC, Inc. has filed an 8-K detailing the departure of Ronald P. Erickson from his roles as Director and President of the Science Division, along with the terms of his separation agreement.

USBC, Inc. has completed the divestiture of its legacy non-invasive sensor technology business to a company controlled by former CEO Ron Erickson to prioritize its tokenized deposit platform.

USBC, Inc. announced it has regained full compliance with NYSE American continued listing standards, resolving previous minimum stockholders equity deficiencies.

USBC, Inc. announced the repricing of 83 million outstanding stock options to an exercise price of $0.37 per share to motivate and retain key personnel.

USBC, Inc. has finalized a strategic partnership with Vast Bank and Uphold HQ Inc. to launch a tokenized deposit network for digital dollar use cases.

USBC, Inc. filed an amended 8-K to correct a signature omission and detail the separation agreement for former Chief Operating Officer Kirk Chapman, including a $320,000 annual severance package.

USBC, Inc. announced the departure of Chief Operating Officer Kirk Chapman, who will receive a $320,000 severance package and forfeit unvested stock options.

USBC, Inc. updated its digital asset management agreement with Hyrcanian Asset Management, clarifying terms for its Bitcoin treasury strategy.

USBC, Inc. announced the mutual departure of its Chief Operating Officer and the withdrawal of several preferred stock designations, with no shares outstanding.

USBC, Inc. announced the resignation of John Cronin from its Board of Directors, effective November 19, 2025.

USBC, Inc. repriced 48.6 million stock options and issued 55 million new equity grants to executives and directors, aiming to boost motivation and retention.

USBC, Inc. stockholders approved an Amended and Restated 2021 Equity Incentive Plan, increasing authorized shares by 65 million, and re-elected eight directors at its Annual Meeting.

USBC, Inc. announced an increase in its at-the-market equity offering program with JonesTrading to a maximum aggregate offering price of $14.5 million to fund general corporate purposes.

USBC, Inc. announced its corporate name and ticker change, signaling a strategic pivot towards digital assets and banking solutions under new CEO Greg Kidd.

Know Labs, Inc. completes a strategic acquisition by Goldeneye 1995 LLC, changes its name to USBC, Inc., and shifts focus to a Bitcoin treasury strategy and digital asset development under new CEO Greg Kidd.

Know Labs, Inc. stockholders have approved a significant increase in authorized common stock to 750 million shares, a substantial expansion of its equity incentive plan, and a private placement leading to a potential change of control.

Know Labs, Inc. has entered into a promissory note agreement with Goldeneye 1995 LLC for a bridge loan of up to $350,000 at a 12% annual interest rate, due by January 28, 2026, or upon demand.

Know Labs, Inc. announces a definitive agreement for Goldeneye 1995 LLC, an affiliate of Greg Kidd, to acquire a controlling interest, pivoting the company to a Bitcoin treasury strategy and appointing Kidd as CEO and Chairman.

Know Labs, Inc. has converted approximately $1.18 million in principal debt owed to an entity affiliated with its CEO into 16,916 shares of a newly created Series H Convertible Preferred Stock, aiming to strengthen its balance sheet.

Know Labs, Inc. announces that the NYSE American will lift the trading suspension of its common stock, effective March 5, 2025, after resolving a listing deficiency related to low selling price.

Know Labs, Inc. announces its common shares have been approved for trading on the OTCQB Venture Market under the ticker symbol 'KNWN', effective February 26, 2025.

Know Labs cancels its special stockholder meeting scheduled for March 7, 2025, after implementing a 1-for-40 reverse stock split.

Know Labs enacts a 1-for-40 reverse stock split to meet NYSE American listing requirements, effective February 19, 2025.

Know Labs, Inc. is facing delisting from the NYSE American due to its low stock price and has begun trading on the OTC Pink Market while it appeals the decision.

Know Labs has announced the formation of Know Labs Technology Licensing (KTL) to monetize its radio frequency dielectric spectroscopy (RFDS) technology across various industries.

Know Labs has secured a Capital on Demand Sales Agreement with JonesTrading, allowing them to potentially sell up to $5 million of common stock.

Know Labs has extended the expiration dates of warrants held by Clayton Struve by five years, as part of an agreement that also extended the maturity dates of certain promissory notes and debentures.

Know Labs has amended multiple senior secured convertible redeemable debentures with Clayton Struve, extending their maturity dates to September 30, 2025.